USCOM in Newly Diagnosed FGR Cases
NCT: NCT06343051 · COMPLETED
NCT IDNCT06343051
StatusCOMPLETED
Start Date2024-07-02
Completion2026-05-07
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated
Brief Summary
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Frequently Asked Questions
What is USCOM in Newly Diagnosed FGR Cases?
USCOM in Newly Diagnosed FGR Cases is a clinical trial registered under NCT06343051. Current status: COMPLETED.
What is the status of NCT06343051?
The current status of NCT06343051 (USCOM in Newly Diagnosed FGR Cases) is: COMPLETED.
When did USCOM in Newly Diagnosed FGR Cases start?
USCOM in Newly Diagnosed FGR Cases started on 2024-07-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.